This article was originally published in The Tan Sheet
Public Citizen's Health Research Group "will be asking the FDA to change the warning labels on both over-the-counter ibuprofen products (such as Advil, Nuprin and Medipren)" and Procter-Syntex' just-approved naproxen sodium Aleve, according to HRG's Health Letter. Prescription-strength ibuprofen and naproxen both carry labels cautioning at-risk populations about the potential for drug-induced kidney failure when using these products. HRG maintained that "important information such as this should be included in all over-the-counter drug labels"
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC